Arcellx, Inc. (ACLX)
73.61
+0.92
(+1.27%)
USD |
NASDAQ |
Dec 12, 10:45
Arcellx Research and Development Expense (TTM): 168.16M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.734B |
| Geron Corp. | 81.32M |
| Daré Bioscience, Inc. | 6.616M |
| Cartesian Therapeutics, Inc. | 54.74M |
| Cabaletta Bio, Inc. | 132.01M |